SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharma - Quaterly Results

05 Nov 2024 Evaluate
The revenue zoomed 7.64% to Rs. 412.16 millions for the quarter ended September 2024 as compared to Rs. 382.89 millions during the corresponding quarter last year.Net Profit recorded in the quarter ended September 2024 rise to 31.14% to Rs. 96.02  millions  compared to R. 73.22 millions in corresponding previous quarter.Operating profit surged to 132.79 millions from the corresponding previous quarter of 102.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 412.16 382.89 7.64 737.52 674.64 9.32 1419.66 1367.49 3.82
Other Income 18.53 10.96 69.07 32.59 21.33 52.79 46.67 51.23 -8.90
PBIDT 132.79 102.00 30.19 239.73 182.04 31.69 377.85 354.90 6.47
Interest 1.16 0.69 68.12 2.31 1.43 61.54 2.71 3.67 -26.16
PBDT 131.63 101.31 29.93 237.42 180.61 31.45 375.14 351.23 6.81
Depreciation 6.39 5.91 8.12 11.58 10.91 6.14 23.40 22.59 3.59
PBT 125.24 95.40 31.28 225.84 169.70 33.08 351.74 328.64 7.03
TAX 29.22 22.18 31.74 55.67 42.79 30.10 91.98 82.58 11.38
Deferred Tax -0.78 -3.48 -77.59 0.67 -2.89 -123.18 -5.21 -2.25 131.56
PAT 96.02 73.22 31.14 170.17 126.91 34.09 259.76 246.06 5.57
Equity 44.13 44.13 0.00 44.13 44.13 0.00 44.13 44.13 0.00
PBIDTM(%) 32.22 26.64 20.94 32.50 26.98 20.46 26.62 25.95 2.55

Jenburkt Pharma Share Price

1025.60 6.35 (0.62%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×